ClearPoint Neuro (CLPT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on ClearPoint Neuro (CLPT) is Neutral.

The composite score behind that read is -0.08, weighing +0.39 of bullish evidence against -0.30 bearish.

ClearPoint Neuro last closed at $10.48, -0.10% on the session.

Against the IVW growth benchmark the position is -0.90% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

ClearPoint Neuro has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks ClearPoint Neuro in the 5th percentile on return on equity, where 100 is best.

ClearPoint Neuro is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $319.99M.

StockMap tracks ClearPoint Neuro as the 86th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite ClearPoint Neuro ranks 84th of 140 in the group, against a group median of -0.03.